TEL/AML1 T(12 21)(ALL), HEPARIN BLOOD

image not found

NABL Cap Accredited    
This test detects the t(12;21)(p13;q22) chromosomal translocation involving the TEL (ETV6) and AML1 (RUNX1) genes, a common genetic abnormality in pediatric acute lymphoblastic leukemia (ALL). Identifying this fusion helps in confirming diagnosis and assessing prognosis, as it is generally associated with a favorable outcome. The test provides critical information for risk stratification and treatment planning. Metropolis Healthcare performs this analysis using advanced molecular techniques for precise and reliable detection

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 4,135.00

Sample Type: Sodium Heparin Blood

Fasting Not Required


Notes: T0010

Frequently Asked Questions (FAQ's):

What does the TEL/AML1 test detect?
It identifies the t(12;21) translocation that creates the ETV6-RUNX1 fusion gene.

Why is this test important?
The fusion gene is an important diagnostic and prognostic marker in childhood ALL.

Does the patient need any preparation?
No special preparation is required for a heparin blood sample.

Who should undergo this test?
Patients, especially children, being evaluated for or diagnosed with acute lymphoblastic leukemia.

How is the test performed?
The laboratory uses sensitive molecular assays such as RT-PCR or FISH to detect the TEL/AML1 fusion.

Is this fusion associated with better outcomes?
Yes, the presence of the ETV6-RUNX1 fusion generally indicates a favorable prognosis.

Are the results reliable?
Yes, Metropolis Healthcare ensures accuracy through validated and high-quality molecular testing methods

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab